Title : Phase II Study of Neoadjuvant Anthracycline-Based Regimens Combined With Nanoparticle Albumin-Bound Paclitaxel and Trastuzumab for Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer.

Pub. Date : 2015 Jun

PMID : 25579459

1 Functional Relationships(s)
Compound Name
Protein Name
1 The present study evaluated the activity and safety of nab-PTX as a neoadjuvant treatment of HER2(+) breast cancer. nab erb-b2 receptor tyrosine kinase 2 Homo sapiens